IMPACT OF COVID-19 ON MYOCARDIAL INFARCTION: A NARRATIVE REVIEW
*Mohamed Said Mohamud, Bo Yang and Yahya Adullaahi Ali
SARS (Severe Acute Respiratory Syndrome) is a form of acute respiratory syndrome. When Coronavirus 2 (SARS-CoV-2) was exposed to cause extreme respiratory distress syndrome at the end of 2019, it drew worldwide interest. Although it mainly influences the respiratory system, research proposes that it also disturbs other organ systems in the human body. Myocardial cardiogenic shock, systolic heart failure, acute coronary syndrome, infarction, life-threatening arrhythmias are all possible cardiac manifestations. Myocardial infarction is becoming more widely accepted as a barrier of Coronavirus-19, and it can occur as a result of either overactive host immune response or a direct viral damage. The analysis is made using a clinical exam, non-invasive imaging trials, laboratory findings, clear history much as most etiologies. The cardiac MRI is chosen imaging modality when it is available. If the condition is still unclear, an endomyocardial biopsy can be done. The current management is primarily positive, with the possibility of including treatments such as steroids, remdesivir and convalescent plasma, which are prescribed for acute COVID-19 illness. Advanced artificial circulatory support systems should be addressed in the case of refractory and cardiogenic shock, life-threatening arrhythmias that occur during surgical treatment. Finally, early detection and aggressive response are critical to lowering morbidity and mortality. Since learning more about COVID-19 disease and its related heart problems, the management approach is likely to change.
Keywords: COVID-19, heart failure, myocardial infarction, coronavirus.
[Full Text Article]